560 results
Type of content
News Remove News filter
Categories
Human Remove Human filter
Responsible body
CHMP Remove CHMP filter
-
List item
News: Update of EU recommendations for 2020/2021 seasonal flu vaccine composition
CHMP, Last updated: 15/05/2020 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 28-30 April 2020
CHMP, Last updated: 30/04/2020 -
List item
Press release: Suspension of ranitidine medicines in the EU
CHMP, Last updated: 30/04/2020 -
List item
Press release: EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine
CHMP, Last updated: 30/04/2020 -
List item
Press release: First triple combination therapy for asthma with optional electronic sensor
CHMP, Last updated: 30/04/2020 -
List item
Press release: Risks of Picato for actinic keratosis outweigh benefits
CHMP, Last updated: 30/04/2020 -
List item
Press release: EMA provides recommendations on compassionate use of remdesivir for COVID-19
CHMP, Last updated: 03/04/2020 -
List item
News: EU recommendations for 2020/2021 seasonal flu vaccine composition
CHMP, Last updated: 01/04/2020 -
List item
Press release: No change to product information for breast cancer medicine Tyverb following re-assessment of data
CHMP, Last updated: 27/03/2020 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 March 2020 (updated)
CHMP, Last updated: 27/03/2020 -
List item
Press release: New gene therapy to treat spinal muscular atrophy (corrected)
CHMP, Last updated: 27/03/2020 -
List item
Press release: No change is needed in use of direct oral anticoagulants following EMA-funded study
CHMP, Last updated: 27/03/2020 -
List item
Press release: Recommendations to restrict use of fosfomycin antibiotics
CHMP, Last updated: 27/03/2020 -
List item
Press release: Benefits of medicines containing combination of methocarbamol and paracetamol continue to outweigh risks
CHMP, Last updated: 27/03/2020 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 February 2020
CHMP, Last updated: 28/02/2020 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-30 January 2020
CHMP, Last updated: 31/01/2020 -
List item
Press release: First oral GLP-1 treatment for type 2 diabetes
CHMP, Last updated: 31/01/2020 -
List item
Press release: First treatment for acute hepatic porphyria
CHMP, Last updated: 31/01/2020 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 December 2019
CHMP, Last updated: 13/12/2019 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 November 2019 (updated)
CHMP, Last updated: 15/11/2019 -
List item
Press release: EMA confirms Xeljanz to be used with caution in patients at high risk of blood clots
CHMP, Last updated: 15/11/2019 -
List item
Press release: Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada
CHMP, Last updated: 15/11/2019 -
List item
News: Enhancing consistency in wording of therapeutic indications to support healthcare decision-making
CHMP, Last updated: 21/10/2019 -
List item
Press release: First vaccine to protect against Ebola
CHMP, Last updated: 14/11/2019 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 October 2019
CHMP, Last updated: 18/10/2019